Chemoinformaics analysis of Isorhynchophylline
| Molecular Weight | 384.476 | nRot | 4 |
| Heavy Atom Molecular Weight | 356.252 | nRig | 23 |
| Exact Molecular Weight | 384.205 | nRing | 4 |
| Solubility: LogS | -3.918 | nHRing | 3 |
| Solubility: LogP | 2.93 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 60.8182 |
| nHD | 1 | BPOL | 35.5778 |
| QED | 0.491 |
| Synth | 4.656 |
| Natural Product Likeliness | 1.881 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.558 |
| Pgp-sub | 0.507 |
| HIA | 0.005 |
| CACO-2 | -4.579 |
| MDCK | 0.0000281 |
| BBB | 0.994 |
| PPB | 0.537252 |
| VDSS | 1.134 |
| FU | 0.361895 |
| CYP1A2-inh | 0.109 |
| CYP1A2-sub | 0.765 |
| CYP2c19-inh | 0.632 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.657 |
| CYP2c9-sub | 0.097 |
| CYP2d6-inh | 0.918 |
| CYP2d6-sub | 0.638 |
| CYP3a4-inh | 0.916 |
| CYP3a4-sub | 0.922 |
| CL | 11.123 |
| T12 | 0.261 |
| hERG | 0.756 |
| Ames | 0.289 |
| ROA | 0.934 |
| SkinSen | 0.779 |
| Carcinogencity | 0.933 |
| EI | 0.01 |
| Respiratory | 0.961 |
| NR-Aromatase | 0.213 |
| Antiviral | No |
| Prediction | 0.61354 |